This content is machine translated Migraine: better quality of life thanks to multimodal care Broader selection of innovative migraine prophylactics and acute therapies The fact that migraine therapy is changing is also reflected in the recent publication of the updated S1 guideline “Treatment of migraine attacks and prophylaxis of migraine”. Although triptans are...…
View Post 6 min This content is machine translated Migraine and vascular regulation CGRP-targeted migraine therapies for vascular risk patients Migraine is one of the most common neurological disorders and affects millions of people worldwide. With the development of CGRP-targeted therapies – monoclonal antibodies and Gepanten – the treatment of...…
View Post 6 min This content is machine translated New evidence on genetics, pathophysiology and clinical significance Migraine with and without aura – two different entities? Migraine is one of the most common neurological disorders, and for decades it has been debated whether migraine with aura (MwA) and migraine without aura (MwoA) are merely different manifestations...…
View Post 7 min This content is machine translated Migraine Curbing attacks through proactive measures Migraines can significantly reduce the quality of life of those affected. Early treatment is therefore advisable if the diagnosis is confirmed. Migraine therapy can be divided into three groups: Acute...…
View Post 4 min This content is machine translated Pain Management Migraines and co. well under control thanks to innovative treatment options Pain patients often wait years for a diagnosis and then usually receive inadequate treatment, as pain is neglected as a central symptom. This care problem was the focus of the…
View Post 4 min This content is machine translated Migraine prophylaxis with CGRP-mAb New sub-analysis on fremanezumab shows risks of treatment breaks At this year’s congress of the European Association of Neurology (EAN) in Helsinki, a sub-analysis of the PEARL data was presented, which shows possible negative effects of treatment breaks on…
View Post 19 min This content is machine translated Headache treatment The therapy of migraine Migraine is one of the most common neurological disorders with a global prevalence estimated at 14-15%. The highest prevalence is between the ages of 35 and 39, and women are… CME-Test
View Post 19 min This content is machine translated Headache treatment The therapy of migraine Migraine is one of the most common neurological disorders with a global prevalence estimated at 14-15%. The highest prevalence is between the ages of 35 and 39, and women are… CME-Test
View Post 19 min This content is machine translated Headache treatment The therapy of migraine Migraine is one of the most common neurological disorders with a global prevalence estimated at 14–15%. The highest prevalence is between the ages of 35 and 39, and women are… CME-Test
View Post 10 min This content is machine translated Neurology Neurodegenerative diseases in the focus of promising therapies This year’s DGN focused on neurodegenerative diseases, as much development has taken place in this area. Promising therapeutic approaches are on the horizon, and molecular biological research has provided important…
View Post 4 min This content is machine translated Pain Medicine Effective and modern care for migraine and co. This year’s Pain and Palliative Day was held under the motto “Worry and care – pain medicine in practice”. In addition to health services research, discussion panels will focus on…
